SCHEMBL6324430

SCHEMBL6324430

Cc1cccc(-c2noc(CCC(=O)O)n2)c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.73
HTT P42858 1/20 0.73
TSHR P16473 4/20 0.70
KMT2A Q03164 2/20 0.70
RAB9A P51151 4/20 0.68
NPC1 O15118 3/20 0.68
L3MBTL1 Q9Y468 2/20 0.68
TDP1 Q9NUW8 2/20 0.68
FFAR1 O14842 1/20 0.64
GLA P06280 1/20 0.64
SMN1; SMN2 Q16637 4/20 0.62
MEN1 O00255 1/20 0.62
ALDH1A1 P00352 1/20 0.61
MAPT P10636 2/20 0.61
LMNA P02545 2/20 0.60
HPGD P15428 1/20 0.60
ATM Q13315 1/20 0.60
RXRA P19793 2/20 0.59
RXRB P28702 2/20 0.59
RXRG P48443 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326164 0.85 ALDH1A1 (0.63) MAPK1HTTTSHRKMT2AFFAR1
SCHEMBL6326326 0.85 ALDH1A1 (0.59) MAPK1HTTTSHRKMT2ARAB9A
SCHEMBL5330405 0.84 ALDH1A1 (0.83) TSHRKMT2ARAB9ANPC1L3MBTL1
SCHEMBL1544736 0.84 TSHR (0.71) MAPK1HTTTSHRKMT2ARAB9A
SCHEMBL6324681 0.84 FFAR1 (0.75) HTTTSHRKMT2AL3MBTL1FFAR1
SCHEMBL27608327 0.84 ALDH1A1 (0.57) MAPK1HTTTSHRKMT2ARAB9A
SCHEMBL3932295 0.83 RAB9A (0.71) MAPK1HTTTSHRKMT2ARAB9A
SCHEMBL1684613 0.83 TSHR (0.74) HTTTSHRKMT2AL3MBTL1FFAR1
SCHEMBL22419403 0.83 ALDH1A1 (0.56) MAPK1HTTTSHRKMT2ARAB9A
SCHEMBL6326329 0.82 FFAR1 (0.60) MAPK1HTTTSHRKMT2AFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9481658-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2016-11-01 US disclosed
US-9481658-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2016-11-01 US disclosed
US-20150080582-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2015-03-19 US disclosed
US-20150080582-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2015-03-19 US disclosed
US-8981108-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2015-03-17 US disclosed
US-8981108-B2 Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound FUJIFILM CORPORATION (JP) 2015-03-17 US disclosed
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND FUJIFILM CORPORATION (JP) 2010-09-23 US disclosed
EP-1423120-A4 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORP (US) 2005-12-28 EP disclosed
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed
EP-1423120-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2004-06-02 EP disclosed
US-20040087588-A1 Parp inhibitors ICOS CORPORATION 2004-05-06 US disclosed
WO-2003015785-A1 2H-PHTHALAZIN-1-ONES AND METHODS FOR USE THEREOF ICOS CORPORATION (US) 2003-02-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040087588-A1 Parp inhibitors PARP1, PARP2, PARP11 MAPK1 922/4885HTT 1266/4885TSHR 4656/4885
US-20150080582-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND PYM1, CCND2, CCNB2 MAPK1 918/4885HTT 2524/4885TSHR 680/4885
US-20100239788-A1 OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND PYM1, CCND2, CCNB2 MAPK1 845/4885HTT 2383/4885TSHR 675/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.